Microwave-Assisted Evaporative Crystallization of Niflumic Acid for Particle Size Reduction by Radacsi, Norbert et al.
Microwave-Assisted Evaporative Crystallization of Niflumic Acid for
Particle Size Reduction
Norbert Radacsi,† Joop H. ter Horst,† and Georgios D. Stefanidis*,†
†Intensified Reaction & Separation Systems, Process & Energy Laboratory, Delft University of Technology, Leeghwaterstraat 44, 2628
CA, Delft, The Netherlands
*S Supporting Information
ABSTRACT: Microwave irradiation can significantly speed up solvent
evaporation in crystallization processes, resulting in rapid crystallization
and reduced particle size. A single-mode microwave setup was used for
evaporative crystallization of the model pharmaceutical compound,
niflumic acid. Production of crystals by microwave irradiation offers a
novel way to particles for drug formulation solving formulation problems
of drugs with low solubility and permeability in class II of the
Biopharmaceutics Classification System. In this work, niflumic acid was
produced using microwave irradiation and conventional heating. The
final product size, as measured by a particle size analyzer, was reduced
when increasing the evaporation rate using microwave irradiation. X-ray diffraction proved that the crystal form after microwave-
assisted crystallization remained unchanged.
Solving bioavailability problems of new active pharmaceut-ical ingredients is a major challenge for the pharmaceutical
industry, since nearly half of the new active substances being
identified in high-throughput screening are either insoluble or
poorly soluble in water.1−3 As the crystallization method
determines the product properties, it is possible to increase the
dissolution rate and reach higher drug bioavailability by
selecting proper crystallization conditions.4,5 Evaporative
crystallization is widely applied in several industrial processes,
including the pharmaceutical industry.
The effect of microwave heating on the evaporative
crystallization of niflumic acid (NIF) is investigated in this
study. NIF is an important active pharmaceutical ingredient,
with anti-inflammatory activity accompanied by an analgesic
effect.6 In accordance with the Biopharmaceutics Classification
System (BCS), NIF belongs to class II, a practically water-
insoluble (26 μg mL−1 at 25 °C), lipophilic, and highly
permeable compound.7 To achieve optimal pharmacodynamic
properties such as a rapid onset of the drug effect, fast
dissolution is essential for this type of drug.
Microwave heating is fundamentally different from conven-
tional (conductive) heating. In particular, microwaves offer
rapid and volumetric heating, without the need of heat transfer
surfaces or heat transfer fluids. In addition, as microwaves
couple directly with the (polar) molecules of the solution, heat
transfer stops immediately when the magnetron is turned off,
thus minimizing thermal inertia. Over the past 30 years, many
interesting phenomena have been observed and reported in
studies on microwave-enhanced chemistry.8 As regards
crystallization, Pinard and Aslan9 reported that microwaves
enable crystallization of glycine from aqueous solutions onto
silver nanostructures coated on glass surface in seconds. The
silver nanoparticles were meant to serve as selective nucleation
sites and as a microwave-transparent medium for the creation
of thermal gradient between the warmer solution and the silver
nanoparticles. The thermal gradient afforded for the mass
transfer and assembly of glycine molecules onto the nano-
particles. Contrary to Pinard and Aslan, we focus on the effect
of microwaves on the solvent evaporation rate and how this
affects crystal size.
Clear undersaturated solutions of NIF in ethanol at two
different concentrations (20 mg mL−1 and 48 mg mL−1) were
prepared, and a 5 mL volume of solution was injected into a
quartz Petri dish. The Petri dish was placed in the middle of the
cavity of the single-mode microwave setup (Figure 1) for the
microwave experiments or on top of a hot plate in the case of
conventional heating experiments. In total, eight different
experimental conditions were investigated.
In the event of microwave heating, heat transfer does not
depend on the thermal conductivity, which is low for
conventional solvents, like water, methanol, or ethanol.10
Rather, it depends on the dielectric properties of the solution.
Ethanol has favorable dielectric properties for microwave
heating, as it has a very high loss tangent (tan δ), a measure
of inherent dissipation of electromagnetic energy of the
material (0.941 at 2.45 GHz).11
When microwave heating is used for solvent evaporation, the
5 mL solution starts boiling within 4 s with maximum
microwave power (300 W) (see Figure S1 of the Supporting
Information) and within 8 s at half of the maximum microwave
power (150 W). The solvent was completely evaporated within
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21 s at 300 W (see the movie of the Supporting Information)
and within 43 s at 150 W (Table 1).
Using conventional heating resulted in significantly larger
times for complete solvent evaporation, even though the
solution started to boil immediately after injection. More
specifically, at 120 °C and 180 °C Petri dish temperatures, at
least 166 and 70 s, respectively, were needed for complete
solvent evaporation of the 20 mg mL−1 solutions (Table 1).
In the evaporation process (either heat conduction- or
microwave-assisted), the time window between the time at
which the solution becomes supersaturated and the time of
complete solvent evaporation is defined as the crystallization
time. During this crystallization time at some point nucleation
and subsequently crystal growth occurs, the rate of both then
determine the final crystal size distribution.
Two process parameters were identified to influence
crystallization time. First is the heat transfer rate, which can
be regulated by the applied microwave power or the Petri dish
surface temperature in the event of conductive (hot plate)
heating. Second is the initial solution concentration. When the
initial concentration is increased, supersaturation is reached
earlier, while the time needed for solvent evaporation remains
the same, which results in a larger crystallization time. The
crystallization time tcryst for all process conditions tested,
together with the relevant product size characterization values
(mean volume diameter and standard deviation), are shown in
Table 1, while the experimental approach to obtain the
crystallization times and the discussion of results follows in the
next paragraphs.
During all the hot plate evaporative crystallization experi-
ments and during the microwave irradiation experiment using
maximum power and 20 mg mL−1 initial solution concen-
tration, the total mass of the solution was monitored. It was
found that the solvent evaporation rate was close to constant,
resulting in a linear change of the cumulative evaporated
solvent mass with time (see Figure S2 of the Supporting
Information). From the solution mass, the mass fraction of the
solute in the solution was calculated and plotted as a function
of time (Figure 2). It was thus assumed that the solvent
evaporation rate is also constant in the other experiments.
In order to determine the crystallization times, the solubility
of NIF in ethanol at different temperatures needs to be known.
The solubility of NIF in ethanol (see Figure S3 of the
Supporting Information) was determined using saturation
temperature measurements of differently concentrated samples.
NIF has a solubility of 56 mg mL−1 at room temperature (25
°C), and an interpolated solubility of around 213 mg mL−1,
equal to a mass fraction of 0.28 at the boiling point of ethanol
(78.3 °C).
It was found that microwave irradiation for evaporative
crystallization results in very small crystallization times due to
the high evaporation rates achieved; this implies high
supersaturation ratios and thus high nucleation rates. As a
result, the mean volume diameter (MV), determined by laser
diffraction particle size analysis, was 25 μm at maximum, in the
microwave experiments. In the hot plate experiments, the
crystal size was found to be significantly larger. In the case of 20
mg mL−1 solution concentration, crystal sizes of around 80 μm
were obtained, while in the case of 48 mg mL−1 initial solution
concentration, even larger sizes were obtained with a minimum
of 110 μm diameter. The standard deviation is also significantly
smaller for the products produced with use of microwaves than
Figure 1. Cutaway view of the used microwave setup showing the
position of the quartz Petri dish and the main parts of the setup.
Table 1. Time Needed for Complete Evaporation (tevap) of 5
mL NIF Dissolved in Ethanol; Crystallization Time (tcryst),
Mean Diameter over Volume (MV) and Standard Deviation
(SD) for the Two Initial Solvent Concentrations (c) Applied,
Under Microwave and Hot Plate Heating
method
c (mg
mL−1)
tevap
(s)
tcryst
(s)
MV
(μm)
SD
(μm)
microwave 300 W 20 20 1.4 25 17
48 21 1.5 19 13.9
microwave 150 W 20 43 2.8 23 15.9
48 41 2.9 23 14.9
hot plate 180 °C 20 78 7.6 81 52.6
48 70 11.5 110 91
hot plate 120 °C 20 166 7.6 79 55
48 167 23.3 209 133
Figure 2. Mass fraction of solute in the solvent. MW stands for
microwave-assisted crystallization, and HP refers to evaporative
crystallization on top of a hot plate. The dashed lines represent the
theoretical lines, assuming constant evaporation rate.
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the products produced on the hot plate (see Table 1). Thus
microwave-assisted evaporative crystallization results in small
crystal size with narrow standard deviation. The crystal size
distributions for each crystallization time are shown in Figure 3.
Next to the larger needle-like crystals, small (1−3 μm) crystals
with compact shapes can be observed (see Figure S4 for SEM
images of the Supporting Information). It can be seen that the
crystal size distributions of the microwave products are
bimodal, which is most probably due to the occurrence of
several nucleation events originating from the nonuniformity of
the electromagnetic field12−14 and the non-optimal constant
evaporation rate during the experiment. At the end of the
experiment, the high evaporation rate leads to extremely high
supersaturation rates, and nucleation might dominate growth,
leading to bimodal crystal size distributions consisting of larger
particles nucleated earlier in the experiment and smaller
particles that nucleated toward the end.
It was found that the final crystal size and the standard
deviation increase approximately linearly with increasing
crystallization time (Figure 4).
X-ray diffraction showed that neither the microwave
irradiation nor the hot plate aided evaporative crystallization
altered the crystal structure of NIF, as compared to that
reported in literature15 (see Figure S5 of the Supporting
Information).
Microwave-assisted evaporative crystallization appears to be a
promising method for crystal size reduction due to fast
evaporation rates generating high supersaturations. It is possible
to scale up microwave reactors toward industrial scale, using a
promising new concept of coupling microwave energy to liquid
solutions. In particular, the INTLI (internal transmission line)
technology allows for effective microwave heating of liquid
mixtures in up to 17 L stainless steel stirred batch reactors at
present.16−19
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